Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
DRMAthis companyDermata Therapeutics, Inc.	$0.81	-0.28×	0.35×	0×	0.69×	916.2%	0.0%	0.0%	0.0%	-121.5%	-124.9%	-361.0%	0×	0.97×	0×	4.79×	0.0%	1	-23.83	2	C+
ARTLArtelo Biosciences, Inc.	$2.00	-0.22×	-2.26×	0×	-0.24×	-565.9%	0.0%	0.0%	0.0%	1012.5%	1919.9%	-296.4%	-0.53×	-0.01×	-58.78×	0.17×	0.0%	2	-17.34	2	C+
ELABPMGC Holdings Inc.	$1.60	-0.38×	0.37×	4.9×	-0.02×	40235.4%	12.7%	-1250.1%	-1306.3%	-98.4%	-70.2%	-220.7%	0.34×	0.38×	-13.48×	1.74×	0.0%	3	-1.94	2	C
GTBPGT Biopharma, Inc.	$4.39	-0.13×	0.75×	0×	0.09×	441.2%	0.0%	0.0%	0.0%	-490.0%	-214.7%	-298.3%	0×	0.24×	-97.81×	3.5×	5.3%	1	-185.96	2	C
REVBRevelation Biosciences, Inc.	$4.00	-0.13×	0.22×	0×	0.88×	2518.1%	0.0%	0.0%	0.0%	-100.6%	-94.4%	-416.3%	0.08×	1.1×	0×	5.41×	0.0%	2	-7.62	2	B-
Peer median	—	-0.18×	0.3×	0×	0.03×	1479.7%	0.0%	0.0%	0.0%	-99.5%	-82.3%	-297.3%	0.04×	0.31×	-36.13×	2.62×	0.0%	2	-12.48	2	—